Biocartis Group NV
XBRU:BCART
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.29
0.29
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Net Margin
Biocartis Group NV
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | BE |
Market Cap | 27m EUR |
Net Margin |
-112%
|
Country | US |
Market Cap | 204.9B USD |
Net Margin |
14%
|
Country | US |
Market Cap | 195.2B USD |
Net Margin |
29%
|
Country | US |
Market Cap | 146.7B USD |
Net Margin |
16%
|
Country | US |
Market Cap | 132.6B USD |
Net Margin |
11%
|
Country | IE |
Market Cap | 110.6B USD |
Net Margin |
12%
|
Country | US |
Market Cap | 64.7B USD |
Net Margin |
9%
|
Country | DE |
Market Cap | 55.6B EUR |
Net Margin |
8%
|
Country | CN |
Market Cap | 319.2B CNY |
Net Margin |
34%
|
Country | US |
Market Cap | 41.6B USD |
Net Margin |
74%
|
Country | US |
Market Cap | 37.7B USD |
Net Margin |
9%
|
Biocartis Group NV
Glance View
Biocartis Group NV which engages in the development of oncology molecular diagnostic solutions. The company is headquartered in Malines (Mechelen), Antwerpen and currently employs 619 full-time employees. The company went IPO on 2015-04-27. The group has the Idylla system to deliver results within a period of between 35 to 150 minutes.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Biocartis Group NV's most recent financial statements, the company has Net Margin of -112%.